Filed: 8/14/2025ACC: 0000950123-25-008066
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $154.44M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$154.44M
Total AUM (reported)
28.46M
Total Shares
Allocation by class
COMMON STOCK$132.63M85.9%
COMMON STOCK CLASS A$21.53M13.9%
WARRANT$273.0K0.2%
Portfolio Concentration
Top 3$78.60M50.9%
4–10$72.40M46.9%
11–25$3.44M2.2%
Top 3 weight
50.9%
Top 10 weight
97.8%
Voting Authority Distribution
Total shares with voting rights: 30.64M
Sole
Full voting authority
30.64M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
Beta Bionics Inc.
SOLEShares1.99M
TypeSH
Market value$28.95M
18.75%
Sole
1.99M
Shared
0.00
None
0.00
Kestra Med Technologies Ltd.
SOLEShares1.65M
TypeSH
Market value$27.29M
17.67%
Sole
1.80M
Shared
0.00
None
0.00
Upstream Bio Inc.
SOLEShares2.04M
TypeSH
Market value$22.36M
14.48%
Sole
2.04M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares11.04M
TypeSH
Market value$21.53M
13.94%
Sole
13.07M
Shared
0.00
None
0.00
Bicara Therapeutics Inc.
SOLEShares2.20M
TypeSH
Market value$20.48M
13.26%
Sole
2.20M
Shared
0.00
None
0.00
Replimune Group
SOLEShares1.98M
TypeSH
Market value$18.35M
11.88%
Sole
1.98M
Shared
0.00
None
0.00
Lexeo Therapeutics
SOLEShares1.18M
TypeSH
Market value$4.76M
3.08%
Sole
1.18M
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$3.01M
1.95%
Sole
2.25M
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$2.30M
1.49%
Sole
843.75K
Shared
0.00
None
0.00
Alumis Inc.
SOLEShares653.22K
TypeSH
Market value$1.96M
1.27%
Sole
653.22K
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares526.36K
TypeSH
Market value$1.92M
1.24%
Sole
526.36K
Shared
0.00
None
0.00
Immunic Inc.
SOLEShares1.79M
TypeSH
Market value$1.25M
0.81%
Sole
1.79M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares321.50K
TypeSH
Market value$273.0K
0.18%
Sole
321.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Beta Bionics Inc.SOLE | Common Stock | 1.99M | SH | $28.95M 18.75% | 1.99M | 0.00 | 0.00 |
Kestra Med Technologies Ltd.SOLE | Common Stock | 1.65M | SH | $27.29M 17.67% | 1.80M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | Common Stock | 2.04M | SH | $22.36M 14.48% | 2.04M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 11.04M | SH | $21.53M 13.94% | 13.07M | 0.00 | 0.00 |
Bicara Therapeutics Inc.SOLE | Common Stock | 2.20M | SH | $20.48M 13.26% | 2.20M | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 1.98M | SH | $18.35M 11.88% | 1.98M | 0.00 | 0.00 |
Lexeo TherapeuticsSOLE | Common Stock | 1.18M | SH | $4.76M 3.08% | 1.18M | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $3.01M 1.95% | 2.25M | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $2.30M 1.49% | 843.75K | 0.00 | 0.00 |
Alumis Inc.SOLE | Common Stock | 653.22K | SH | $1.96M 1.27% | 653.22K | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 526.36K | SH | $1.92M 1.24% | 526.36K | 0.00 | 0.00 |
Immunic Inc.SOLE | Common Stock | 1.79M | SH | $1.25M 0.81% | 1.79M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Warrant | 321.50K | SH | $273.0K 0.18% | 321.50K | 0.00 | 0.00 |